The American Heart Association has partnered with health tech company Cadence to launch a home care program aimed at reducing 30-day readmissions for heart failure patients. Participating hospitals can refer patients to the Connected Care program prior to discharge, a…
The Latest
Boise, Idaho-based St. Luke’s Regional Medical Center had the lowest 30-day readmission rate for heart failure patients between July 1, 2021, and June 30, 2024, according to CMS data published Aug. 6. The CMS measure is based on unplanned readmissions…
Eli Lilly’s oral GLP-1, orforglipron, led to significant weight loss and blood sugar reductions in a late-stage clinical trial. In the phase 3 study, adults with obesity, were overweight and with Type 2 diabetes lost an average of 10.5% of…
Shannon Levesque has been named Nashua, N.H.-based Southern New Hampshire Health’s first chief people officer. In her new role, Ms. Levesque will lead workforce development and talent strategy to help the health system meet area needs, according to an Aug.…
A higher body mass index in older adults is associated with lower 30-day mortality rates after major elective surgery, according to research published Aug. 26 in JAMA. A BMI above 25 has been linked to worse postoperative outcomes in the…
As hospitals and health systems expand their use of AI, leaders say clear communication with boards and executives is essential to temper enthusiasm with realistic expectations. Rohit Chandra, PhD, chief digital officer at Cleveland Clinic, described AI as a promising…
UT Medical Center has expanded its longstanding partnership with the University of Tennessee Knoxville College of Nursing by investing in a new facility and additional scholarships for students. Four notes: 1. Over the past five years, the institutions’ collaboration has…
Eversana, a pharmaceutical distributor and marketing company, has acquired a software company with plans to disrupt “the industry’s misaligned incentives and fragmented patient experiences,” according to an Aug. 26 news release. The acquired firm, Waltz Health, offers prescription drug-pricing technology…
With drug costs rising, workforce shortages intensifying, and new therapies reshaping care delivery, pharmacy leaders are facing more complexity — and responsibility — than ever. That’s why Becker’s is bringing together hundreds of health plan leaders to transform the industry.…
AbbVie is acquiring Gilgamesh Pharmaceuticals’ lead drug candidate bretisilocin, used to treat moderate to severe major depressive disorder, for up to $1.2 billion. Bretisilocin is a psychedelic compound that targets the 5-HT2A receptor and releases serotonin, according to an Aug.…